AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25048646 — intervention group
Group type: EXPERIMENTAL
Intervention: Nondrug, nonoperative interventions
Number of subjects: 591
Study 24182579 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-osteoperforations
Number of subjects: 20
Study 24182579 — intervention group
Group type: COMPARATOR
Intervention: Control group (no micro-osteoperforations)
Number of subjects: 20
Study 21804624 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured psychological intervention conducted by a nurse
Number of subjects: 0
Study 21804624 — intervention group
Group type: COMPARATOR
Intervention: Routine preparation for venipuncture (Control group)
Number of subjects: 0
Study 19664895 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 668
Study 19664895 — intervention group
Group type: COMPARATOR
Intervention: Control (no statin treatment)
Number of subjects: 668
Study 16595583 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanthanum carbonate (LC) at a median dose of 1250 mg for 1 year
Number of subjects: 20
Study 16595583 — intervention group
Group type: COMPARATOR
Intervention: Calcium carbonate (CC) during the whole study period (3 years)
Number of subjects: 20
Study 15239415 — intervention group
Group type: EXPERIMENTAL
Intervention: Mismatched pairs (concrete/abstract)
Number of subjects: 56
Study 15239415 — intervention group
Group type: COMPARATOR
Intervention: Matched concrete pairs
Number of subjects: 56
Study 15239415 — intervention group
Group type: COMPARATOR
Intervention: Matched abstract pairs
Number of subjects: 56
Study 15239415 — intervention group
Group type: EXPERIMENTAL
Intervention: All three subset groups combined
Number of subjects: 56
Study 11554654 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgrastim
Number of subjects: 56
Study 11554654 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 9042628 — intervention group
Group type: EXPERIMENTAL
Intervention: salmeterol 50 micrograms
Number of subjects: 14
Study 9042628 — intervention group
Group type: EXPERIMENTAL
Intervention: salbutamol 200 micrograms
Number of subjects: 14
Study 9042628 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 14
Study 8181200 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (150 units/kg)
Number of subjects: 6
Study 8181200 — intervention group
Group type: COMPARATOR
Intervention: Control (vehicle)
Number of subjects: 6
Study 3370063 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg i.v. over 1 h
Number of subjects: 9
Study 3370063 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg p.o.
Number of subjects: 9
Study 3370063 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg p.o.
Number of subjects: 9
Study 3370063 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal clearance of metabolites
Number of subjects: 9
Study 31521756 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial peripheral neuromuscular blockade group
Number of subjects: 60
Study 31521756 — intervention group
Group type: COMPARATOR
Intervention: Free of neuromuscular blockade group
Number of subjects: 60
Study 31521756 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 29089192 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-staphylococcal vaccine
Number of subjects: 18688
Study 29089192 — intervention group
Group type: COMPARATOR
Intervention: Control group (no vaccine)
Number of subjects: 18688
Study 25837193 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine 0.186% (group R)
Number of subjects: 58
Study 25837193 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine plus 5 μg of sufentanil (group RS)
Number of subjects: 58
Study 25837193 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromage scale of motor block examination
Number of subjects: 58
Study 25837193 — intervention group
Group type: EXPERIMENTAL
Intervention: Onset time of sensory block
Number of subjects: 58
Study 23216616 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-hematocrit group (target hematocrit <45%)
Number of subjects: 365
Study 23216616 — intervention group
Group type: COMPARATOR
Intervention: High-hematocrit group (target hematocrit 45 to 50%)
Number of subjects: 365
Study 23216616 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-hematocrit group
Number of subjects: 365
Study 23216616 — intervention group
Group type: COMPARATOR
Intervention: High-hematocrit group
Number of subjects: 365
Study 23216616 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 365
Study 21315210 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinolysis (FL)
Number of subjects: 1168
Study 21315210 — intervention group
Group type: COMPARATOR
Intervention: Primary percutaneous coronary intervention (PCI)
Number of subjects: 1168
Study 21315210 — intervention group
Group type: EXPERIMENTAL
Intervention: Both FL and PCI
Number of subjects: 1168
Study 19589258 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate-protocol group
Number of subjects: 115
Study 19589258 — intervention group
Group type: COMPARATOR
Intervention: Traditional-protocol group
Number of subjects: 115
Study 16544586 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster up-dosing scheme (3 weeks duration, 19 patients)
Number of subjects: 38
Study 16544586 — intervention group
Group type: COMPARATOR
Intervention: Traditional up-dosing scheme (13 weeks duration, 19 patients)
Number of subjects: 38
Study 16544586 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster up-dosing scheme
Number of subjects: 38
Study 16544586 — intervention group
Group type: COMPARATOR
Intervention: Traditional up-dosing scheme
Number of subjects: 38
Study 12727580 — intervention group
Group type: EXPERIMENTAL
Intervention: Genistein (54 mg/d)
Number of subjects: 79
Study 12727580 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen/progestin therapy (17beta-estradiol [1 mg/d] combined with norethisterone acetate [0.5 mg/d])
Number of subjects: 79
Study 11078489 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality-of-life scores after relapse
Number of subjects: 2000
Study 9367464 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide, 1,000 microg bid for 4 days
Number of subjects: 10
Study 9367464 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 1342877 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical acetylsalicylic acid (ASA) eye drops (1% solution), applied as one drop in each eye four times a day (q.i.d.) for 14 days.
Number of subjects: 0
Study 1342877 — intervention group
Group type: COMPARATOR
Intervention: Placebo eye drops, applied as one drop in each eye q.i.d. for 14 days.
Number of subjects: 0
Study 2856903 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxmetidine, 600 mg bedtime
Number of subjects: 80
Study 2856903 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 31246796 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine (266 mg)
Number of subjects: 44
Study 31246796 — intervention group
Group type: COMPARATOR
Intervention: Conventional bupivacaine (75 mg)
Number of subjects: 44
Study 30236824 — intervention group
Group type: EXPERIMENTAL
Intervention: mtDNA haplogroup M8*
Number of subjects: 628
Study 30236824 — intervention group
Group type: EXPERIMENTAL
Intervention: m.8684C>T (marker for hg M8a)
Number of subjects: 628
Study 30236824 — intervention group
Group type: COMPARATOR
Intervention: Total antioxidant capacity
Number of subjects: 628
Study 26099760 — intervention group
Group type: EXPERIMENTAL
Intervention: aScope 2
Number of subjects: 60
Study 26099760 — intervention group
Group type: COMPARATOR
Intervention: Karl Storz fibrescope
Number of subjects: 60
Study 23895239 — intervention group
Group type: EXPERIMENTAL
Intervention: Test of Everyday Attention (TEA) forms AB, BC, CA
Number of subjects: 90
Study 23895239 — intervention group
Group type: EXPERIMENTAL
Intervention: Reliable Change Index corrected for practice effect (RCIp)
Number of subjects: 90
Study 21251705 — intervention group
Group type: EXPERIMENTAL
Intervention: Active compression-decompression CPR with augmented negative intrathoracic pressure
Number of subjects: 2470
Study 21251705 — intervention group
Group type: COMPARATOR
Intervention: Standard CPR (control)
Number of subjects: 2470
Study 17940544 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A+beta-carotene (VA+BC)
Number of subjects: 626
Study 17940544 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamins (MV)
Number of subjects: 626
Study 17684364 — intervention group
Group type: EXPERIMENTAL
Intervention: Geranylgeranylacetone (GGA) 150 mg/day for 2 weeks
Number of subjects: 40
Study 17684364 — intervention group
Group type: EXPERIMENTAL
Intervention: DIC 75 mg/day plus GGA 150 mg/day for 2 weeks
Number of subjects: 40
Study 17684364 — intervention group
Group type: COMPARATOR
Intervention: DIC 75 mg/day plus placebo (lactose 1.5 g/day) for 2 weeks
Number of subjects: 40
Study 17684364 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose 1.5 g/day) for 2 weeks
Number of subjects: 40
Study 15293423 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime & Bond NT, Dentsply/Caulk (2 coats and one cure)
Number of subjects: 60
Study 15293423 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Bond, 3M Espe (2 coats and one cure)
Number of subjects: 60
Study 15293423 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime & Bond NT, Dentsply/Caulk (2 coats and 2 cures)
Number of subjects: 60
Study 15293423 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Bond, 3M Espe (2 coats and 2 cures)
Number of subjects: 60
Study 15293423 — intervention group
Group type: EXPERIMENTAL
Intervention: Prime & Bond NT, Dentsply/Caulk (one coat with B1 flowable resin)
Number of subjects: 60
Study 15293423 — intervention group
Group type: EXPERIMENTAL
Intervention: Single Bond, 3M Espe (one coat with B1 flowable resin)
Number of subjects: 60
Study 12055417 — intervention group
Group type: EXPERIMENTAL
Intervention: Normotensives without a family history of hypertension
Number of subjects: 212
Study 12055417 — intervention group
Group type: COMPARATOR
Intervention: Untreated and uncontrolled hypertensives
Number of subjects: 212
Study 12055417 — intervention group
Group type: EXPERIMENTAL
Intervention: Treated and controlled hypertensives
Number of subjects: 212
Study 12055417 — intervention group
Group type: EXPERIMENTAL
Intervention: Normotensives with a family history of hypertension
Number of subjects: 212
Study 9641712 — intervention group
Group type: EXPERIMENTAL
Intervention: Group well-child care (GWCC)
Number of subjects: 213
Study 9641712 — intervention group
Group type: COMPARATOR
Intervention: Individual well-child care (IWCC)
Number of subjects: 213
Study 9715718 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymptomatic carotid surgery trial (ACST) intervention
Number of subjects: 1657
Study 9715718 — intervention group
Group type: COMPARATOR
Intervention: Doppler ultrasound evaluation
Number of subjects: 1657
Study 9715718 — intervention group
Group type: COMPARATOR
Intervention: Data collection methods
Number of subjects: 1657
Study 9715718 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued recruitment in ACST
Number of subjects: 1657
Study 1914803 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized method (Food-meter)
Number of subjects: 21
Study 1914803 — intervention group
Group type: COMPARATOR
Intervention: Conventional method (diary)
Number of subjects: 21
Study 6136745 — intervention group
Group type: EXPERIMENTAL
Intervention: dynamically oriented individual psychotherapy (10 hour-long sessions over 3 months)
Number of subjects: 101
Study 6136745 — intervention group
Group type: COMPARATOR
Intervention: medical treatment
Number of subjects: 101
Study 31640705 — intervention group
Group type: EXPERIMENTAL
Intervention: EQW + SGLT2i
Number of subjects: 1147
Study 31640705 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1147
Study 31640705 — intervention group
Group type: COMPARATOR
Intervention: EQW
Number of subjects: 1147
Study 29526281 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling
Number of subjects: 459
Study 29526281 — intervention group
Group type: COMPARATOR
Intervention: No Counseling
Number of subjects: 459
Study 26959184 — intervention group
Group type: EXPERIMENTAL
Intervention: PF-05231023
Number of subjects: 0
Study 26959184 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 25464680 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro acupuncture therapy (10 sittings over 30 days)
Number of subjects: 60
Study 25464680 — intervention group
Group type: COMPARATOR
Intervention: Conventional drug therapy (oral flunarizine 20 mg OD and paracetamol 500 mg SOS for 30 days)
Number of subjects: 60
Study 23155310 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture dragging combined with pad compression (SDPC)
Number of subjects: 60
Study 23155310 — intervention group
Group type: COMPARATOR
Intervention: Fistulotomy (FSLT)
Number of subjects: 60
Study 20387411 — intervention group
Group type: EXPERIMENTAL
Intervention: Precocious eating/digestion
Number of subjects: 0
Study 18972594 — intervention group
Group type: EXPERIMENTAL
Intervention: Etodolac
Number of subjects: 30
Study 18972594 — intervention group
Group type: EXPERIMENTAL
Intervention: Nimesulid
Number of subjects: 30
Study 18972594 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen sodium
Number of subjects: 30
Study 15616030 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (1,800 IU daily)
Number of subjects: 89
Study 15616030 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 12611732 — intervention group
Group type: EXPERIMENTAL
Intervention: Phospholipid-coated extracorporeal circulation (ECC) materials
Number of subjects: 0
Study 12611732 — intervention group
Group type: COMPARATOR
Intervention: Noncoated ECC materials (Control)
Number of subjects: 0
Study 9650124 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (165 mg)
Number of subjects: 58
Study 9650124 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 58
Study 7775563 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold blood cardioplegia (Group A)
Number of subjects: 100
Study 7775563 — intervention group
Group type: COMPARATOR
Intervention: Crystalloid cardioplegia (Group B)
Number of subjects: 100
Study 3378856 — intervention group
Group type: EXPERIMENTAL
Intervention: Tizanidine 3 mg
Number of subjects: 12
Study 3378856 — intervention group
Group type: EXPERIMENTAL
Intervention: Tizanidine 6 mg
Number of subjects: 12
Study 3378856 — intervention group
Group type: COMPARATOR
Intervention: Diazepam 10 mg
Number of subjects: 12
Study 3378856 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 29227845 — intervention group
Group type: EXPERIMENTAL
Intervention: D-cycloserine (DCS) during 12-session exposure-based group CBT
Number of subjects: 169
Study 29227845 — intervention group
Group type: COMPARATOR
Intervention: Pill placebo during 12-session exposure-based group CBT
Number of subjects: 169
Study 29227845 — intervention group
Group type: EXPERIMENTAL
Intervention: D-cycloserine (DCS)
Number of subjects: 169
Study 29227845 — intervention group
Group type: COMPARATOR
Intervention: Pill placebo
Number of subjects: 169
Study 29129190 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT) protocol for AUD, sessions five and six of a 12-session protocol
Number of subjects: 146
Study 24569031 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of bone marrow-derived cells (BMCs)
Number of subjects: 204
Study 24569031 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 204
Study 23362832 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute hypoxic (HY: FI O2 0.13)
Number of subjects: 14
Study 23362832 — intervention group
Group type: COMPARATOR
Intervention: Normoxic (NM: FI O2 0.21)
Number of subjects: 14
Study 20659185 — intervention group
Group type: EXPERIMENTAL
Intervention: Microcrystalline cellulose membrane (Veloderm) applied every 5-10 days for 1 month after surgical debridement
Number of subjects: 55
Study 18825145 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotherapy
Number of subjects: 0
Study 18825145 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0
Study 18825145 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation therapy or multimodal therapy (combination of relaxation therapy, education, and psychotherapy)
Number of subjects: 0
Study 18825145 — intervention group
Group type: COMPARATOR
Intervention: Mindfulness meditation
Number of subjects: 0
Study 17261891 — intervention group
Group type: EXPERIMENTAL
Intervention: Blueberin (300 mg, 3 times per day for 4 weeks)
Number of subjects: 42
Study 17261891 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 13129472 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin (135 mg capsaicin/d)
Number of subjects: 91
Study 13129472 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study 10452228 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate drinks (CHO)
Number of subjects: 8
Study 10452228 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate drinks with BCAA (CHO+BCAA)
Number of subjects: 8
Study 10452228 — intervention group
Group type: COMPARATOR
Intervention: Flavored water placebo (P)
Number of subjects: 8
Study 9033699 — intervention group
Group type: EXPERIMENTAL
Intervention: Rilmenidine (1 mg once or twice a day)
Number of subjects: 51
Study 9033699 — intervention group
Group type: COMPARATOR
Intervention: Captopril (50 to 100 mg per day, in 2 divided doses)
Number of subjects: 51
Study 1349757 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluspirilene (1.5 mg per week)
Number of subjects: 1261
Study 1349757 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluspirilene (0.5, 1.0, or 1.5 mg per week)
Number of subjects: 1261
Study 1349757 — intervention group
Group type: COMPARATOR
Intervention: Fluspirilene (max 1.5 mg/week)
Number of subjects: 1261
Study 4047153 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodic breast cancer screening
Number of subjects: 1000
Study 4047153 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammography screening
Number of subjects: 1000
Study 4047153 — intervention group
Group type: EXPERIMENTAL
Intervention: Other screening modalities
Number of subjects: 1000
Study 4047153 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening maintenance
Number of subjects: 1000
Study 4047153 — intervention group
Group type: COMPARATOR
Intervention: Control group (no screening)
Number of subjects: 1000
Study 29511047 — intervention group
Group type: EXPERIMENTAL
Intervention: IdeS-cleavage of IgG in samples from local IgG poor microenvironments
Number of subjects: 0
Study 29511047 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 27181277 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive therapy group (IT group; n = 22) - combined moderate intensity aerobic and resistance training three times per week for 12 weeks
Number of subjects: 42
Study 27181277 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy group (CT group; n = 20) - metformin and diet control
Number of subjects: 42
Study 23334213 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Number of subjects: 110
Study 23334213 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 23334213 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 110
Study 22430976 — intervention group
Group type: EXPERIMENTAL
Intervention: Single oral dose of ferroquine (400 to 1200 mg)
Number of subjects: 82
Study 22430976 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated oral dose of ferroquine (400 to 800 mg over 3 days)
Number of subjects: 82
Study 22430976 — intervention group
Group type: COMPARATOR
Intervention: Single administration of 100 mg of ferroquine
Number of subjects: 82
Study 19949779 — intervention group
Group type: EXPERIMENTAL
Intervention: Turning rate controlled using a steering wheel and speed controlled using a foot pedal.
Number of subjects: 0
Study 19949779 — intervention group
Group type: COMPARATOR
Intervention: Comparison across groups with different maximum speed capabilities.
Number of subjects: 0
Study 19949779 — intervention group
Group type: EXPERIMENTAL
Intervention: Subjects recalibrating to changes in maximum speed.
Number of subjects: 0
Study 18633048 — intervention group
Group type: EXPERIMENTAL
Intervention: parecoxib 20 mg bid
Number of subjects: 479
Study 18633048 — intervention group
Group type: EXPERIMENTAL
Intervention: parecoxib 20 mg qd
Number of subjects: 479
Study 18633048 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 479
Study 16158793 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-layered heat- and pressure-laminated EVA mouthguard
Number of subjects: 22
Study 16158793 — intervention group
Group type: COMPARATOR
Intervention: Single-layered vacuum-formed EVA mouthguard
Number of subjects: 22
Study 12354679 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivitamin-multimineral supplementation (VITALIA-tablets)
Number of subjects: 101
Study 12354679 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 10192755 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine 50 mg as a single oral dose
Number of subjects: 12
Study 10192755 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 200 mg as a single oral dose
Number of subjects: 12
Study 7547520 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical head and neck irradiation
Number of subjects: 26
Study 2197382 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal midazolam 0.25 mg/kg
Number of subjects: 80
Study 2197382 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal midazolam 0.35 mg/kg
Number of subjects: 80
Study 2197382 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal midazolam 0.45 mg/kg
Number of subjects: 80
Study 2197382 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 6117434 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ranitidine administration
Number of subjects: 16
Study 6117434 — intervention group
Group type: COMPARATOR
Intervention: 1 mg/kg body wt ranitidine infusion
Number of subjects: 16
Study 6117434 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine (implied control)
Number of subjects: 16
Study 31964340 — intervention group
Group type: COMPARATOR
Intervention: Internal fixation (IF)
Number of subjects: 1440
Study 31964340 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroplasty
Number of subjects: 1440
Study 31964340 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 1440